In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.
AUTOR(ES)
Vila, J
RESUMO
Antimicrobial susceptibility testing was performed on 54 epidemiologically unrelated clinical isolates of Acinetobacter baumannii by using a standard agar dilution technique. On the basis of the in vitro activities, imipenem and doxycycline were the most active agents, whereas amikacin, isepamicin, and the new fluorquinolones ciprofloxacin and ofloxacin presented moderate activity. Cephalosporinase activity was found in 98% of the strains, whereas lactamases of TEM type 1 and one with a pI of 7 to 7.5 were present in 16 and 11% of the strains, respectively. Resistance to aminoglycosides was explained by the production of the three classes of aminoglycoside-modifying enzymes, with predominance of aminoglycoside-3'-phosphotransferase VI in 28% of the strains.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187622Documentos Relacionados
- Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.
- Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in Acinetobacter.
- Aminoglycoside-Modifying Enzymes Among Clinical Isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola): Explanation for High-Level Aminoglycoside Resistance
- Nomenclature of Genes Encoding Aminoglycoside-Modifying Enzymes
- Microplate phosphocellulose binding assay for aminoglycoside-modifying enzymes.